5M PRODUCT
Tykerb 250mg Lapatinib Ditosylate tablet
Anticancer PHARMACEUTICAL PRODUCT

Tykerb 250mg Lapatinib Ditosylate tablet

Strength 250 MG
Published by 5M Biotech India
Last updated 24 October 2026
Company Profile →
PRODUCT INFORMATION

About Tykerb 250mg Lapatinib Ditosylate tablet

Product information published by 5M Biotech India.

Active Ingredient Lapatinib
Brand Tykerb
Country of origin India
Form Oral Tablet

Tykerb 250mg tablet contains lapatinib as the active compound and is an effective treatment for advanced breast cancer.

Clinical Uses

Tykerb 250mg tablet is used to treat advanced breast cancer. It is used alone or in combination with other medicines for better results.

How It Works

Tykerb 250 mg tablet works against HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor). These receptors are responsible for the over-proliferation of cells. This helps Tykerb tablets to inhibit the growth of cancerous cells causing downstream signaling pathways.

Side Effects

A few side effects of taking Tykerb 250mg tablet include-

  • loss of appetite
  • Stomach pain
  • Yellow eyes or skin
  • Headache
  • Difficulty in breathing
  • Dark urine
  • Severe diarrhoea
  • Skin rash
  • Back pain or Joint pain
  • Fatigue
  • Nausea

If any of these side effects persist for too long you should consult a healthcare provider immediately.

Precautions & Warnings

  • Before taking Tykerb 250mg tablet inform your doctor if you have kidney or liver disease.
  • The use of Tykerb tablet is not recommended during breastfeeding and pregnancy.
  • This medicine can cause side effects that may affect your ability to drive.
  • Drink enough water as this medicine can cause diarrhea.
  • It is important to monitor your blood pressure while taking this medicine.
  • It lowers platelet and white blood cells which may make you more prone to infection.

Drug Interactions

A few medicines that can interact with Tykerb 250 mg tablet include-

  • afatinib
  • darolutamide
  • erythromycin base
  • fentanyl
  • ketoconazole
  • macimorelin
  • palifermin
  • ritonavir

This is not the list of all the medicines that can interact with Tykerb tablet. Consult a doctor before taking this medicine with any other supplement and medication.

Disclaimer

At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.

All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.

All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.

Publisher 5M Biotech India
Last Updated 24 October 2026
Product Record #658
Therapeutic Area Anticancer
PRODUCT ENQUIRY

Discuss Tykerb 250mg Lapatinib Ditosylate tablet